chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First dose on 27-Jan -2021 and Second dose 27-Aug-2021; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 27-Jan -2021 and Second dose 27-Aug-2021) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 27-Jan -2021 and Second dose 27-Aug-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 27-Jan -2021 and Second dose 27-Aug-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported.  Treatment details were not given   This case was linked to MOD-2022-503785 (Patient Link).
Left upper arm very swollen, red, warm with presence of bruising under (L) deltoid area and excoriations from scratching arm. Mother stated that her daughter spiked a fever of 103 axillary on 1/17/08 at 3 AM and was given Tylenol. Client was referred to pediatrician to r/o infection or other problems.
pt recv vax 25MAY95 & exp pain @ inj site lt arm lasted 3 to 4 days & h/a that lasted 1 wk;
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 27-AUG-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Patient was given 0.3ml of undiluted Pfizer Covid-19 vaccine. The patient is not having any adverse events at this time.
Patient stopped by Pharmacy consultation window on 05/19/2021 and asked if arm and shoulder pain could have been associated with the covid vaccine he received. He received his Pfizer covid vaccine on 05/05/2021 in his right arm.  He stated that after the vaccine he had a sore arm for a few days and then the bilateral shoulder pain and increased pain in the right arm started a few days after that. He also has arthritis and asked if that could be his arthritis flaring up.  He also mentioned he gets cortisone shots in his arms. He wanted to know if he should get his second dose (which would be due in a week) in his left arm instead.  I informed him that it's hard to tell  and I could not rule out either if it's the vaccine or the arthritis since the pain is in both shoulders and he stated he has a history of arthritis. I encouraged him to check with his physician to rule out arthritis and to determine if it is the vaccine and whether he should receive the second dose.  He said he would consult with his physician before his second dose vaccine date.  I asked him to let us know what his Physician says and he said he would.
Patients arm was red, swollen, hot 2 days after shots were given right arm.
She might have had a stroke in the past; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) at the age of 58 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "She might have had a stroke in the past ".  Clinical course: The caller mentioned that she is 58-year-old and has had two shots of the Pfizer COVID-19 vaccine. She never got her booster; she was supposed to get it, but she never did. She also asked if she had a stroke in the past, should worry about getting the booster shot. Resolutions: - Gathered the caller's concern or inquiry -Gathered the caller's demographics (unable to verify the caller's name since we were not allowed to spell out their name back) -Privacy statement has been provided. -informed her that PMI is closed but she can call them during the weekdays -Provided the PMI and HOO numbers -End call - Precautionary AE form: (Withheld) She might have had a stroke in the past and she did not get her booster. Medical Information: Forwarded to MI: Yes, medical inquiry was forwarded to MI.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient developed urticaria in various sizes scattered on face, chest and extremities. Patient did not have any shortness of breath. This urticaria developed with minutes of immunization.
her lymph nodes are very swollen and painful on her right side; nausea; itchiness; swelling; extreme pain on her right arm and back; migraine; fever -100°f; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine) and PYREXIA (fever -100°f) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Cholesterol and Fibromyalgia.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine) and PYREXIA (fever -100°f). On 08-Mar-2021, the patient experienced NAUSEA (nausea). On an unknown date, the patient experienced LYMPH NODE PAIN (her lymph nodes are very swollen and painful on her right side). The patient was treated with LORAZEPAM (ATIVAN) for Adverse event, at a dose of 1.25 milligram. At the time of the report, PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine), PYREXIA (fever -100°f), NAUSEA (nausea) and LYMPH NODE PAIN (her lymph nodes are very swollen and painful on her right side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included High blood pressure medication and Cholesterol medication for an unknown indication.
Site: Swelling at Injection Site-Medium, Systemic: swelling of the left armpit-Medium, Systemic: Lymph Node Swelling-Medium
Chest pain; Increased heart rate; Blurred/dark vision; Light headedness; Weakness; Increased temperature; Cold sweats; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Sep2021 at 14:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as not applicable and the patient's had allergies to oranges, dust, birch, elm, mulberry, ragweed, oak, cats, dogs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fexofenadine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown start date and unknown if ongoing. On 08Sep2021 at 21:30, the patient experienced chest pain, increased heart rate, blurred/dark vision, light headedness, weakness, increased temperature followed by cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain, increased heart rate, blurred/dark vision, light headedness, weakness, increased temperature and cold sweats was unknown at the time of reporting.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Started out with fever and chills, which lasted for 3 full days. On 1/27/16, patient developed a measles-like rash on face, inside mouth, diaper area, neck, hands, and feet. Minimal rash on torso and back. She also developed chicken pox sores. She had headache and very swollen cheeks with large amount of drooling. The rash and chicken pox are not completely gone and it is now 2/3/2016.
patient developed low grade fever the day following his vaccines. on or near 11/8/2020, patient developed red marks at vaccine site as well as down the arm
3/11/14 - Lt arm pain, red, swollen, hot after receiving TDAP 2/28/14.
Muscle aches; back pain; nausea; fatigue; headache; This is a spontaneous report from a contactable nurse reporting for the patient. A 32-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscular on 18Dec2020 at 14:15 (at the age of 32-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included postural orthostatic tachycardia syndrome (POTS), Fibromyalgia, Migraines, Post-traumatic stress disorder (PTSD), anxiety, depression, and gastrooesophageal reflux disease (GERD), all from an unknown date. The patient did not have any allergies to medications, food or other products. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. The patient did receive concomitant medications within 2 weeks of vaccination (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Dec2020, the patient experienced muscle aches, back pain, nausea, fatigue, and headache. Therapeutic measures were not given for the events. The clinical outcome of the events muscle aches, back pain, nausea, fatigue, and headache was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt started with fever & blistery rash over trunk & extremities on 2/14/13. Most of the rash noted over the hyperpigmented aspects of child's body due to his diagnosis of Incontinentia Pigmenti (IP). The rash is now just present as flaky skin at medial aspect of lower legs, both axilla & (R) forearm. Some of the darker pigmented skin from IP got darker after reaction. Fever resolved after 4 days.
Felt disoriented soon after injection but that cleared within 5 minutes. On arising next AM, tongue and lips were swollen. primary MD advised 2 Benadryl - Urgent Care RX'd Zantac 150, Xyzal and Prednisone
06/07/2005 Dad stated baby had Fever 104 degrees and took him to ER.  Gave him Tylenol, and later his temperature went down.  06/08/2005 called said baby was fine, no temperature.
Typical redness, swelling, itching at the site of injection noticed after 24 hours of vaccination.
Little red blistery spots appeared in October 2022. Some itched and some didn't. Some scabbed and some didn't. The first treatment was clobetasol liquid. The second treatment was clobetasol ointment. I saw the doctor and was diagnosed as a lichen rash. After the CEREVE treatment didn't work I was prescribed another treatment. Recently I saw my pulmonologist and told me it is not a lichen rash. When it's all over like this it is condition related to an autoimmune disorder.
This spontaneous case reported by a consumer, describes the occurrence of pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 21, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 22, 2021, patient experienced pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea. At the time of the report, pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea outcome: unknown. Action taken with mRNA-1273 in response to the event: not applicable. Treatment information not reported.
Client told registrar she had not had a flu vaccine that year. This information was not checked in the Immunization Information System and client was given dose of flu vaccine. It was later determined she had received a dose on 11/16/2021.
hearing loss; Tinnitus; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration (at the age of 36-years-old), administered in Arm Left on 30Mar2021 (Lot Number: ER8730) as single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no known allergies. There were no concomitant medications. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 36-years-old), administered in Arm Left on 02Mar2021 04:00 PM (lot number: EN6205) as single dose for COVID-19 immunization. The patient experienced hearing loss and tinnitus on 30Mar2021. No treatment received for adverse events. The outcome of the events was not recovered. The event hearing loss was considered as serious (medically significant).  Facility type vaccine was Pharmacy or Drug Store. No other vaccine in four weeks. No other medications in two weeks. Not diagnosed with COVID prior vaccination. Not COVID tested post vaccination.
SIDE EFFECTS LASTED 24 HOURS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced side effects lasted 24 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from side effects lasted 24 hours on MAR-2021. This report was non-serious.
episodes of blank stares, sl quivering & crying lasting 2 to 3 seconds;
Initial report was received from a health care professional on 23 September 2010. A 71 year-old patient with an unreported past medical history, had received FLUZONE HIGH-DOSE, lot number U3601AA (route and site of administration not reported) on 23 September 2010 and "that night" following vaccination, experienced red eyes, diarrhea and a temperature of 101 degrees Fahrenheit. No further information was provided at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
patient reported feeling unpleasant, had fever (>100 F) , body aches, chills. This lasted for about 24 hours.
Systemic: Confusion-Medium, Systemic: Shakiness-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Visual Changes/Disturbances-Medium, Systemic: Weakness-Medium, Additional Details: Pt has a h/o seizures and states he felt similar to the feeling before a seizur. his vison was "going in and out" and "back and forth" not neccessarily blurry, his extremities felt tingly and he felt overall faint
Pain left deltoid; hurts when raising arm, headache, and temp of 99. No treatment recommended.
I received the COVID19 vaccine on January 22, 2021. I started to have chest tightness and somewhat of a dry cough midday on Monday January 25, which continued until January 27. I started having congestion and runny nose on January 27, so I went and got tested for COVID on the 27. The test came back positive on January 28. On January 28 I had extreme congestion and head pressure, a bad burning sensation from my left sinus that went back to my left 2nd molar, and a runny nose. I had not gone anywhere the week prior due to studying for an exam besides to lab at school twice where everyone was socially distanced and was wearing a mask the whole time. The highest my temperature got was 99.4 with Tylenol on January 28. In addition to this, my husband got covid tested on January 28 to see if he had it, or had given covid to me and his test came back negative. We had not socially distanced and still had physical contact the entire time, and continued not to do so in our house. We have had full contact the entire time because he is working from home and most of my school is online, and he got tested again on January 30 and came back negative again. If somehow I got covid from school in a short amount of time with everyone wearing a mask, how would he not get covid from me after a full week of exposure unless I was not contagious, which makes me think I somehow got it from the vaccine. I have had adverse reactions to vaccines in the past, as I got the shingles when I was 4 as a direct result from the first chickenpox vaccine.
by 6 day started with itching, all over body, by day 7-8  develop severe urticaria all over body, was put on 3 different antihistamines by my physician with no improvement, then I was put on prednisone for 10 day, finished course and hives and itching are control with daily Antihistamines but I know have dermatographia and have been referred to an allergist and dermatologist. It has been a month since my Moderna booster and no signs of dermatographia  improving.
Cystoid macular degeneration; Neovascular age-related macular degeneration; Choroidal Neovascularization; Posterior Vitreous Detachment; Adult-onset vitelliform macular dystrophy; Blurred Vision; Hypermetropia; Macular pseudohole Bilateral; Regular astigmatism; Presbyopia; foveomacular vitelliform dystrophy/ vitelliform lesions; Macular cyst; Macular hole; cataract Bilateral; Serous retinal detachment; This case was reported by a lawyer and described the occurrence of macular cyst in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   The initial information was received on 22 April 2020 via medical record. As per record the patient prescribed with Shingrix vial kit on 12 June 2018 and on 12 October 2018. The patient had Macular cyst, hole or pseudohole Bilateral, Hypermetropia Bilateral, Regular astigmatism, Presbyopia, Combined forms of age-related cataract Bilateral dated on 05 September 2018. The patient diagnosed with Serous retinal detachment, bilateral dated on 19 September 2018. The patient had Cystoid macular degeneration, bilateral dated on 30 May 2019. On 18 December 2019 the patient visited to doctor for Neovascular (AMD-Age-Related Macular Degeneration) with Active CNV(Choroidal Neovascularization), Adult-Onset Foveomacular Vitelliform Dystrophy, he had Blurred Vision gradual during 1 to 2 years. Artificial Tears 1 gtt prn OU. The patient had Posterior Vitreous Detachment dated on 15 may 2019. The patient had vitelliform lesions in the central macula of both eyes dated on 04 October 2018.
Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.; Itching; Red spot; A little swelling; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot), VACCINATION SITE SWELLING (A little swelling), VACCINATION SITE PAIN (Soreness), ERYTHEMA (Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.) and PRURITUS (Itching) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot), VACCINATION SITE SWELLING (A little swelling) and VACCINATION SITE PAIN (Soreness). On 15-Jan-2021, the patient experienced ERYTHEMA (Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.) and PRURITUS (Itching). On 06-Jan-2021, VACCINATION SITE PAIN (Soreness) had resolved. On 10-Jan-2021, VACCINATION SITE ERYTHEMA (Red spot) and VACCINATION SITE SWELLING (A little swelling) had resolved. At the time of the report, ERYTHEMA (Redness -Each day has gotten larger. The redness increased each day down towards the elbowand under you arm.) and PRURITUS (Itching) had not resolved. Not Provided          On 13-Apr-2021, the patient reported that "things are fine now" and declined further follow-up.
12 hrs after shot began to get chills, then developed a temp Of 103, lasting for 2 days, aches, pains and extreme lethargy.
Fever, redness, swelling to left deltoid 19cm x 11cm in size. Painful to touch.
Pt received vaccines and at 15-30 minutes after shots, had severe asthma exacerbation in office with desats to 80% RA, pale and diaphoretic. Pt is still hospitalized.
The patient did not report any adverse events after being vaccinated.; The patient received an improperly stored vaccine M-M-R on unspecified date between 18-MAR-2020 to 24-MAR-2020.; This spontaneous report has been received from a physician, regarding to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported.  On an unspecified day in March 2020 (also reported as "between 18-MAR-2020 and 24-MAR-2020"), the patient was vaccinated with an improperly stored Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) administered subcutaneously (SC) as prophylaxis (dose, frequency and expiration date were not reported); the lot number S027461 was an invalid lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live. In addition, the physician stated that it was determined from the stability data, that the suspect vaccine was stable, and that the patient did not report any adverse events after being vaccinated. Additional information was not expected.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2003USA006671: US-009507513-2004USA001737: US-009507513-2004USA001738: US-009507513-2004USA001739: US-009507513-2004USA001740: